Background illustration for clinical trials search

Paid Clinical Trials Glendale

Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

for
Systemic Lupus Erythematosus, Rheumatoid Arthritis
Location: Tustin CA, Red Oak TX, Houston TX, Jackson TN,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07607964

Phase 1, Recruiting

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Los Angeles CA, Duarte CA, San Francisco CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07226843

Phase 1, Recruiting

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Los Angeles CA, Duarte CA, Orange CA, Stanford CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05614739

Phase 1, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Los Angeles CA, Duarte CA, La Jolla CA, Stanford CA,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

for
Irritable Bowel Syndrome, Constipation
Location: Los Alamitos CA, Anaheim CA, Lancaster CA, Mesa AZ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07545772

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

for
Irritable Bowel Syndrome, Diarrhea
Location: Los Alamitos CA, Anaheim CA, Lancaster CA, Mesa AZ,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07545759

Phase 2, Recruiting

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

for
Carcinoma, Squamous Cell
Location: Los Angeles CA, Duarte CA, La Jolla CA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 60+

Code: NCT04892173

Phase 3, Recruiting

Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study

for
Cancer, Immunotherapy, Fatigue Related to Cancer Treatment,
Location: Orange CA, Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT07581080

Recruiting

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

for
Sickle Cell Disease
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 1 - 30

Code: NCT03279094

Phase 1, Recruiting

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

for
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Location: Los Angeles CA, Orange CA, San Francisco CA, Tucson AZ,
Sponsor: TopAlliance Biosciences

Sex: All

Age: 18+

Code: NCT04137900

Phase 1, Recruiting

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

for
Multiple Myeloma
Location: Duarte CA, Irvine CA, Houston TX, Milwaukee WI,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07555938

Phase 3, Recruiting

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

for
Atopic Dermatitis, Eczema, Atopic
Location: Santa Monica CA, Northridge CA, Huntington Beach CA,
Sponsor: Pfizer

Sex: All

Age: 18 - 64

Code: NCT07216027

Phase 2, Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

for
Meningioma
Location: Santa Monica CA, San Francisco CA, Phoenix AZ,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07428616

Phase 2, Recruiting

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

for
Type 2 Diabetes Mellitus, T2DM
Location: Santa Clarita CA, Las Vegas NV, Mesa AZ,
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18 - 70+

Code: NCT07527650

Phase 2, Recruiting

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

for
Polycythemia Vera
Location: Orange CA, Houston TX, Grand Rapids MI, Columbus OH,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07429266

Phase 3, Recruiting

Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers

for
Venous Ulcer, Foot Ulcer, Diabetic
Location: Arcadia CA, Austin TX, New Iberia LA, New Orleans LA,
Sponsor: Tides Medical

Sex: All

Age: 18+

Code: NCT02838784

Recruiting

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Los Angeles CA, Irvine CA, Oklahoma City OK, Austin TX,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase 1, Recruiting

Trial of DFP-14927 in Advanced Solid Tumors

for
Solid Tumor, Cancer
Location: Los Angeles CA, Houston TX
Sponsor: Delta-Fly Pharma, Inc.

Sex: All

Age: 18+

Code: NCT03943004

Phase 1, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Los Angeles CA, San Francisco CA, Gilbert AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase 2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Los Angeles CA, Torrance CA, La Jolla CA, San Diego CA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting